In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

In addition to taking medication, paying attention to these habits can help maintain healthy blood pressure levels..resistant ...

Topline data were announced from a phase 3 trial that evaluated baxdrostat in patients with uncontrolled or treatment resistant hypertension.

“Baxdrostat BaxHTN Phase III trials on patients with uncontrolled or treatment-resistant hypertension demonstrated a ...

Struggling to control high BP? Learn about resistant hypertension, its causes, and expert-approved ways to manage it. Get ...

AstraZeneca AZN reported positive top-line results from a late-stage study evaluating the safety, tolerability and efficacy ...

AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a ...

The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.

At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients ...

David’s blood pressure was dangerously high until he received specialized care and renal denervation at BIDMC’s Complex ...

USA: Aldosterone synthase inhibitor lorundrostat has demonstrated meaningful blood pressure-lowering effects in patients with ...